RxDoctor Payments Data

Christopher McAninch, MD

Vascular Surgery · Plymouth, MNNPI 1215370085

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,558 of the $5,600 with a category attached, or 81.4%. It is spread thinly across 15 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,443 and has fallen 52.5% since, to $685 in 2025.

$5,600in general payments, 2019–2025

Across 70 payments — averaging $80.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$1K
  • Medtronic$801
  • Silk Road Medical, Inc.$753
  • W. L. Gore & Associates, Inc.$653
  • Philips North America LLC$575
  • Shockwave Medical, Inc$519
  • plus $1K from 9 others

What the payments were for

  • Consulting fees$4508%
  • Travel & lodging$59211%
  • Food & beverage$4,55881%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,600 in reported general payments places this provider in the 65th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$64,710
Medicare patients
125
Services billed
271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban15$14,377
Cilostazol101$2,693
ClopidogrelClopidogrel Bisulfate83$1,509
Pentoxifylline11$1,040
Mupirocin12$82
Chlorhexidine Gluconate13$53

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Plymouth

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →